Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceIntermittent preventive treatment for malaria in children living in areas with seasonal transmissionOral iron supplements for children in malaria-endemic areasHome- or community-based programmes for treating malariaOral iron supplements for children in malaria-endemic areasOral iron supplementation for preventing or treating anaemia among children in malaria-endemic areasChemoprophylaxis and intermittent treatment for preventing malaria in childrenEpidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining controlThe impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectivesGametocytaemia after drug treatment of asymptomatic Plasmodium falciparumLong-term impact of malaria chemoprophylaxis on cognitive abilities and educational attainment: follow-up of a controlled trialA trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese childrenDuration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infantsIntermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trialThe cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan AfricaIntermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trialDeterminants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and childrenThe use of formative research to inform the design of a seasonal malaria chemoprevention intervention in northern NigeriaMalaria Policy Advisory Committee to the WHO: conclusions and recommendations of sixth biannual meeting (September 2014).From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control.Exploring the impact of targeted distribution of free bed nets on households bed net ownership, socio-economic disparities and childhood malaria infection rates: analysis of national malaria survey data from three sub-Saharan Africa countries.Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, GhanaUnderstanding and retention of the informed consent process among parents in rural northern Ghana.Modelling the epidemiological impact of intermittent preventive treatment against malaria in infants.Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial.Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysisEffectiveness of combined intermittent preventive treatment for children and timely home treatment for malaria control.Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum infections on clinical malaria risk.Community effectiveness of intermittent preventive treatment for infants (IPTi) in rural southern TanzaniaModelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children.Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.WHO policy development processes for a new vaccine: case study of malaria vaccines.Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children.Clustering of under-five mortality in the Navrongo HDSS in the Kassena-Nankana District of northern Ghana.Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants.Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan AfricaEstimation of summary protective efficacy using a frailty mixture model for recurrent event time data.
P2860
Q21032450-9C3F285E-DA62-4962-8884-A6A8AC922B4BQ21032527-CCF0103F-7817-4656-9863-3FD4F696A50CQ24186101-D8DD4653-7300-477D-9C59-B15152F84BF9Q24202898-03CF89AE-B59C-4C86-A559-3827A27EE8E8Q24235999-5EC1B015-56E4-4477-8802-7711F8A68356Q24240003-0C76A834-65A6-4178-BA99-28A7C6AE26B7Q24243240-C2DC79B9-B28B-4229-9D36-BB4BA7967B56Q24656072-B7383EB5-B327-462F-8058-1006AC210BC9Q27344985-F64570CF-D113-49C7-AAAB-887D4A9BDB3BQ28469180-180392FB-1973-4D49-A59A-A2A3B6AF7CA5Q28469181-B13B3483-EBD9-449F-9DEC-88D47E784536Q28471975-5C436859-710E-4BAA-AC17-08745B46F3AEQ28473083-45C11C18-9E50-449C-9AD6-235C1512777CQ28473566-CCD1C187-3624-4646-9D68-2290D3673AFEQ28474404-43A06A0A-2BA3-40B1-A21A-DA6B4E197C8EQ28477053-A0F2C56F-58C7-4139-9A64-ADDB605DF044Q28477679-B58C2E77-3D09-4CC1-A905-0E1805A43F61Q30381724-C04D9316-8B13-49A8-9E7A-50398A9723F1Q30389020-A98F4C67-AADE-429C-8D3D-B2E47028B5B1Q30483321-A4F5791B-B23E-4CD0-87C4-03872745878FQ30655338-6A6A731D-529D-412D-841E-5AF22DB1B96BQ33336570-568F8AF7-9FD4-47A2-9B50-1BD5540694ACQ33345037-DB6B2273-8366-4EEA-AFBD-7DC5F3EE611BQ33351939-8A17F3B1-6C1E-4320-A26D-EF60812F1BAFQ33394777-857CA0AE-00EC-4A40-8C0B-138DB9B7F511Q33529052-482D80FA-2004-49B1-B7BE-ED0B0406C104Q33552780-85863AAD-7F8F-4B70-B837-8CA1F47523FEQ33645358-88B3B8CC-67DE-44F4-808D-B972E8EAD864Q33691573-995DE567-AE11-4B31-A110-A8B0AB722270Q33737542-2B17DAA8-8571-4C0A-845B-8FDCDCF04038Q33817569-B9059087-FBC4-4487-8EA8-CDA95B025346Q33886209-2A59E8E4-0825-4235-9058-CF7A432122BCQ33964491-E671D67C-5615-4DC8-801C-98D081B812CCQ33999559-289AAFCA-A7D6-465D-94A3-465E1FD0B295Q34008911-0B647419-11F9-4384-A34B-982C9161C473Q34025033-0A37305D-6C21-4D40-8A13-B7EC2538EAA3Q34112576-F0B3D42B-B8E6-4465-B163-F7385F13F623Q34128601-0EF236DC-349B-482D-AAC6-74AF7A3F8DDBQ34271078-914FC877-52BD-4FF0-9D21-8943821C86D2Q34327206-B9A2C5A2-1BCA-4E2F-AD45-AB53076C0C15
P2860
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Cluster randomised trial of in ...... easonal transmission in Ghana.
@ast
Cluster randomised trial of in ...... easonal transmission in Ghana.
@en
type
label
Cluster randomised trial of in ...... easonal transmission in Ghana.
@ast
Cluster randomised trial of in ...... easonal transmission in Ghana.
@en
prefLabel
Cluster randomised trial of in ...... easonal transmission in Ghana.
@ast
Cluster randomised trial of in ...... easonal transmission in Ghana.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Cluster randomised trial of in ...... easonal transmission in Ghana.
@en
P2093
Fred Binka
Ilona Carneiro
Kwame Amponsa-Achiano
Nathan Mensah
Rita Baiden
Shabbar Jaffar
P2860
P304
P356
10.1136/BMJ.331.7519.727
P407
P577
2005-10-01T00:00:00Z